Difference between revisions of "Corona Vaccins First Dose Efficacy"
From Tech
Jump to navigationJump to search (→Pfizer) |
(→Pfizer) |
||
Line 3: | Line 3: | ||
[[File:Screenshot_2021-07-11_at_11-28-03_Safety_and_Efficacy_of_the_BNT162b2_mRNA_Covid-19_Vaccine_NEJM.png|x200px|Efficacy of BNT162b2 (Pfizer) against Covid-19 after the First Dose.]] |
[[File:Screenshot_2021-07-11_at_11-28-03_Safety_and_Efficacy_of_the_BNT162b2_mRNA_Covid-19_Vaccine_NEJM.png|x200px|Efficacy of BNT162b2 (Pfizer) against Covid-19 after the First Dose.]] |
||
+ | |||
+ | [https://www.nejm.org/doi/pdf/10.1056/NEJMoa2101765?articleTools=true#page=7 Vaccinated vs Unvaccinated in BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting] |
||
+ | |||
+ | [[File:Screenshot 2021-07-11 at 12-37-30 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting - NEJMoa2101765.png|x200px|Vaccinated vs Unvaccinated in BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting]] |
||
=Moderna= |
=Moderna= |